Cargando…

SLT-VEGF Reduces Lung Metastases, Decreases Tumor Recurrence, and Improves Survival in an Orthotopic Melanoma Model

SLT-VEGF is a recombinant cytotoxin comprised of Shiga-like toxin (SLT) subunit A fused to human vascular endothelial growth factor (VEGF). It is highly cytotoxic to tumor endothelial cells overexpressing VEGF receptor-2 (VEGFR-2/KDR/Flk1) and inhibits the growth of primary tumors in subcutaneous mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ackerman, Rachel, Backer, Joseph M., Backer, Marina, Skariah, Sini, Hamby, Carl V.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3153293/ https://www.ncbi.nlm.nih.gov/pubmed/22069683 http://dx.doi.org/10.3390/toxins2092242

Ejemplares similares

Targeted scVEGF/(177)Lu radiopharmaceutical inhibits growth of metastases and can be effectively combined with chemotherapy
por: Rusckowski, Mary, et al.
Publicado: (2016)

Imaging VEGF receptor expression to identify accelerated atherosclerosis
por: Tekabe, Yared, et al.
Publicado: (2014)

Long-Term Outcomes of Selective Laser Trabeculoplasty (SLT) Treatment
por: Ayala, Marcelo, et al.
Publicado: (2011)

Predictive factors of success in selective laser trabeculoplasty (SLT) treatment
por: Ayala, Marcelo, et al.
Publicado: (2011)

Baseline Factors Predictive of SLT Response: A Prospective Study
por: Bruen, Robin, et al.
Publicado: (2012)

Substrates of the MAPK Slt2: Shaping Yeast Cell Integrity
por: González-Rubio, Gema, et al.
Publicado: (2022)

Hsp90 and phosphorylation of the Slt2(Mpk1) MAP kinase activation loop are essential for catalytic, but not non-catalytic, Slt2-mediated transcription in yeast
por: Millson, Stefan H., et al.
Publicado: (2022)

Local and Recurrent Regional Metastases of Melanoma
por: Perez, Matthew C., et al.
Publicado: (2019)

Clinicopathological Characteristics Predicting Further Recurrence and Survival Following Resection of In-Transit Melanoma Metastases
por: Lawless, Anna K., et al.
Publicado: (2022)

IOP Maintenance in SLT-treated Eyes following Subsequent Phacoemulsification and IOL
por: Ansari, Ejaz
Publicado: (2013)

Influence of Selective Laser Trabeculoplasty (SLT) on the iStent inject® outcomes
por: Maier, Anna-Karina B., et al.
Publicado: (2020)

VEGF receptor targeted imaging of angiogenic response to limb ischemia in diabetic vs. non-diabetic Yucatan minipigs
por: Johnson, Lynne L., et al.
Publicado: (2020)

Identification of Toxoplasma gondii Genes Responsive to the Host Immune Response during In Vivo Infection
por: Skariah, Sini, et al.
Publicado: (2012)

NRF3 Decreases during Melanoma Carcinogenesis and Is an Independent Prognostic Marker in Melanoma
por: Immonen, Anni, et al.
Publicado: (2022)

Cgl-SLT2 is required for appressorium formation, sporulation and pathogenicity in Colletotrichum gloeosporioides
por: Yong, H.Y., et al.
Publicado: (2014)

Endothelium-Independent Vasodilatory Effect of Sailuotong (SLT) on Rat Isolated Tail Artery
por: Yeon, S. Y., et al.
Publicado: (2020)

Self-measurement of IOP by patients with normal tension glaucoma before and after SLT
por: Young, Alexandra, et al.
Publicado: (2021)

The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer
por: Dineen, Sean P, et al.
Publicado: (2008)

Adenoviral targeting of malignant melanoma for fluorescence-guided surgery prevents recurrence in orthotopic nude-mouse models
por: Yano, Shuya, et al.
Publicado: (2015)

Comparison of selective laser trabeculoplasty (SLT) in primary open angle glaucoma and pseudoexfoliation glaucoma
por: Ayala, Marcelo, et al.
Publicado: (2011)

A second component of the SltA-dependent cation tolerance pathway in Aspergillus nidulans
por: Mellado, Laura, et al.
Publicado: (2015)

Proteolytic activation of both components of the cation stress–responsive Slt pathway in Aspergillus nidulans
por: Mellado, Laura, et al.
Publicado: (2016)

COVID‐19 and ENT SLT services, workforce and research in the UK: A discussion paper
por: Patterson, Joanne M, et al.
Publicado: (2020)

Soluble lytic transglycosylase SLT of Francisella novicida is involved in intracellular growth and immune suppression
por: Nakamura, Takemasa, et al.
Publicado: (2019)

Differential Role of Threonine and Tyrosine Phosphorylation in the Activation and Activity of the Yeast MAPK Slt2
por: González-Rubio, Gema, et al.
Publicado: (2021)

Neuroendocrine Liver Metastases and Orthotopic Liver Transplantation: The US Experience
por: Nguyen, N. Thao T., et al.
Publicado: (2011)

Imaging Key Biomarkers of Tumor Angiogenesis
por: Backer, Marina V., et al.
Publicado: (2012)

Patient-Derived Orthotopic Xenograft (PDOX) Models of Melanoma †
por: Hoffman, Robert M.
Publicado: (2017)

Melanoma risk loci as determinants of melanoma recurrence and survival
por: Rendleman, Justin, et al.
Publicado: (2013)

Bacteriophage Treatment: Critical Evaluation of Its Application on World Health Organization Priority Pathogens
por: AL-Ishaq, Raghad Khalid, et al.
Publicado: (2020)

The role of VEGF in melanoma progression
por: Rajabi, Parvin, et al.
Publicado: (2012)

The yeast mitogen-activated protein kinase Slt2 is involved in the cellular response to genotoxic stress
por: Soriano-Carot, María, et al.
Publicado: (2012)

Assessment and management of the communication difficulties of children with cerebral palsy: a UK survey of SLT practice
por: Mary Watson, Rose, et al.
Publicado: (2015)

Phosphorylation by the stress-activated MAPK Slt2 down-regulates the yeast TOR complex 2
por: Leskoske, Kristin L., et al.
Publicado: (2018)

Selective laser trabeculoplasty (SLT) performed by optometrists—enablers and barriers to a shift in service delivery
por: Konstantakopoulou, Evgenia, et al.
Publicado: (2021)

Commentary: A twist on pulmonary artery translocation
por: Backer, Carl L.
Publicado: (2021)

Commentary: The new frontier of intracardiac mapping
por: Backer, Carl L.
Publicado: (2022)

Determinants of survival in patients with brain metastases from cutaneous melanoma
por: Staudt, M, et al.
Publicado: (2010)

Metastatic melanoma: prognostic factors and survival in patients with brain metastases
por: Frinton, E., et al.
Publicado: (2017)

Survival in melanoma brain metastases in the era of novel systemic therapies
por: Merola, Joseph P, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5si4i0d77jr7dhtu3451nfji6o